Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...

Dexcom, a San Diego biotech company known for its continuous glucose monitoring systems, is laying off a few hundred workers as it moves its operations and manufacturing from California to Arizona.

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 3.3% in the afternoon session after company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference on Wednesday ...

SEASON. HY-VEE EMPLOYEE IN IOWA IS GOING ABOVE AND BEYOND WITH HER HELPFUL SMILE. YES, AS SHE WALKED INTO WORK THIS MORNING, SHE WAS GREETED WITH A BIG SURPRISE. SHE LOOKS SHOCKED. JULIE HEADLEY IS ...

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Prosper Junior Bakiny is a contributing Motley Fool healthcare ...

Dexcom, a glucose-monitoring company based in San Diego, is laying off 350 employees. The company announced Wednesday that it was cutting 3% of its global workforce. Of the 350 laid off, 196 workers ...

When markets are trading near record levels the number of stocks getting Strong Buy consensus recommendations with high potential price upside tends to go down. But that doesn't mean there aren't ...

Dexcom, the San Diego-based maker of continuous glucose monitors for diabetes patients and prediabetics, announced Wednesday that it is laying off around 350 workers, or 3% of its global workforce.

Dexcom, the company that specializes in continuous glucose monitoring systems, announced Wednesday that it would be laying off 3% of its workforce. (Cheng Xin/Getty Images) Dexcom, a ...

We recently published 10 Stocks Bleeding Early. DexCom, Inc. (NASDAQ:DXCM) is one of the worst-performing stocks on Monday. DexCom fell for a fifth straight day on Monday, shedding 3.82 percent to ...

CNBC's "The Exchange" team discusses the potential of tariffs on pharmaceuticals, U.S. manufacturing and more with Dexcom CEO and chairman Kevin Sayer. ‘We are arresting the mayor right now, per the ...